CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Haemato AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Haemato AG
Lilienthalstrasse 3a
Phone: +49 30897308670p:+49 30897308670 SCHOENEFELD, 12529  Germany Ticker: HAEKHAEK
Business Summary
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company operates in two segments specialty pharma and lifestyle and aesthetics. Specialty pharma segment includes the trade and production of drugs and preparations in the field of human immunodeficiency virus (HIV), oncology, rheumatology, neurology as well as cardiovascular diseases and other chronic diseases. Its lifestyle and aesthetics segment is an outcome of new subsidiary M1 Aesthetics GmbH which is into marketing of pharmaceutical, medical and med tech products for aesthetic surgery and cosmetic dermatology. The Company acts as a wholesaler and parallel importer. Its business is carried out by there companies Haemato pharma AG, Haemato Med GmbH, M1 Aesthetics GmbH. It offers related support services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairwoman of the Supervisory Board AndreaGrosse 57 5/30/2013 5/30/2013
Deputy Chairman of the Supervisory Board SabineMeck 67 1/1/2013 12/7/2007
Member of the Management Board PatrickBrenske 11/30/2020 11/30/2020
Member of the Management Board AttilaStrauss 4/1/2021 4/1/2021
Member of the Supervisory Board UweZimdars 3/9/2021 7/20/2017

Business Names
Business Name
HAE1
HAEK
WINDSOR AG

General Information
Number of Employees: 78 (As of 12/31/2022)
Outstanding Shares: 5,212,106 (As of 6/30/2023)
Stock Exchange: HAM
Fax Number: +49 30897308679


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025